A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Local Institution - 0041, Albany

Lancaster General Hospital, Lancaster

Local Institution - 0036, Norfolk

Local Institution - 0037, Greenville

Local Institution - 0081, Orlando

Local Institution - 0089, Miami

Local Institution - 0063, Nashville

Local Institution - 0064, Louisville

Local Institution - 0039, Cincinnati

Local Institution - 0065, Indianapolis

Local Institution - 0101, Southfield

Local Institution - 0069, Wichita

Local Institution - 0097, Dallas

Local Institution - 0096, Tyler

Baylor Scott and White Health, Temple

Local Institution - 0061, San Antonio

Local Institution - 0060, Denver

Local Institution - 0074, Salt Lake City

Local Institution - 0057, Los Angeles

Local Institution - 0051, Portland

Local Institution - 0098, Eugene

Local Institution - 0052, East Brunswick

Local Institution - 0066, Morristown